| Stage | XOM | % of rev | PBF | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $113B | 100.00% | $12.1B | 100.00% | XOM ×9.33 |
| Gross profit | $36.2B | 32.01% | $2.2B | 17.89% | XOM +14.1pp |
| Operating income | $21.4B | 18.93% | $2.1B | 17.32% | XOM +1.6pp |
| Pre-tax income | $21.2B | 18.77% | $2.0B | 16.87% | XOM +1.9pp |
| Net income | $16.0B | 14.16% | $1.5B | 12.72% | XOM +1.4pp |
| Stage | XOM | PBF | Gap · A − B |
|---|---|---|---|
| Revenue | $113B100.00% | $12.1B100.00% | XOM ×9.33 |
| Gross profit | 32.01%$36.2B | 17.89%$2.2B | XOM +14.1pp |
| Operating income | 18.93%$21.4B | 17.32%$2.1B | XOM +1.6pp |
| Pre-tax income | 18.77%$21.2B | 16.87%$2.0B | XOM +1.9pp |
| Net income |
| 14.16%$16.0B |
| 12.72%$1.5B |
| XOM +1.4pp |
No shared counterparties.